PubRank

R J Arceci

Author PubWeight™ 49.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 1989 2.35
2 Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev 1987 2.24
3 The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci U S A 1993 2.09
4 Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993 1.43
5 Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005 1.40
6 Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 1990 1.39
7 Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol 1998 1.26
8 Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995 1.23
9 Absence of colony-stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod 1996 1.20
10 Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 1989 1.18
11 Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol 2006 1.17
12 Allelotype of pediatric rhabdomyosarcoma. Oncogene 1997 1.13
13 STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity. Oncogene 2001 1.12
14 Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 2001 1.12
15 Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. Cancer Res 2000 1.07
16 Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer 1993 1.04
17 Histone variants and chromatin structure during sea urchin development. Dev Biol 1980 1.03
18 The programmed switch in lysine-rich histone synthesis at gastrulation. Cell 1976 1.01
19 mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J Biol Chem 1992 0.98
20 Congenital and neonatal leukemia. Semin Perinatol 1999 0.97
21 Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis. J Clin Invest 1994 0.95
22 Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996 0.93
23 An SNF2 factor involved in mammalian development and cellular proliferation. Dev Dyn 2001 0.91
24 Activating mutations of c-kit at codon 816 confer drug resistance in human leukemia cells. Leuk Lymphoma 2001 0.90
25 Sea urchin sperm chromatin structure as probed by pancreatic DNase I: evidence for a noval cutting periodicity. Dev Biol 1980 0.89
26 Noncoincidence of histone and DNA synthesis in cleavage cycles of early development. Proc Natl Acad Sci U S A 1977 0.87
27 Expression and ontogeny of murine CD2. Eur J Immunol 1989 0.87
28 Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 1998 0.87
29 Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 1996 0.86
30 Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development. Bioessays 1991 0.85
31 Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev Biol 1996 0.85
32 Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. Blood 1995 0.84
33 P-glycoproteins encoded by mdr 1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylated. FEBS Lett 1989 0.81
34 Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells. Blood 1989 0.81
35 Lymphokine expression profile of resting and stimulated CD4+ CTL clones specific for the glycoprotein of vesicular stomatitis virus. Cell Immunol 1993 0.81
36 Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. J Clin Oncol 2000 0.81
37 A gamma delta+ T-cell leukemia bearing a novel t(8;14)(q24;q11) translocation demonstrates spontaneous in vitro natural killer-like activity. Blood 1992 0.80
38 Histone gene expression: progeny of isolated early blastomeres in culture make the same change as in the embryo. Science 1980 0.79
39 P-glycoprotein is expressed in the mineralizing regions of the skeleton. Calcif Tissue Int 1996 0.79
40 Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol 1997 0.79
41 HTLV-III infection after bone marrow transplantation. Blood 1986 0.78
42 P-glycoprotein mediates profound resistance to bisantrene. Oncol Res 1994 0.78
43 Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model. J Pediatr Hematol Oncol 1998 0.77
44 Histones of sea urchin embryos. Transients in transcription, translation, and the composition of chromatin. Dev Biol 1978 0.77
45 Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cells Mol Dis 2001 0.77
46 Langerhans cell histiocytosis: an uncommon disease commonly manifesting in the craniofacial skeleton. Plast Reconstr Surg 1996 0.76
47 Fever and neutropenia: changing patterns of medical practice. J Pediatr Hematol Oncol 2000 0.75
48 Comments from the Editor-in-Chief. J Pediatr Hematol Oncol 1999 0.75
49 Clinical trials and tribulations. J Pediatr Hematol Oncol 2001 0.75
50 Melanocyte populations of yellow and black hair bulbs in the mouse. J Hered 1975 0.75
51 Unconventional therapies: "eyes wide shut". J Pediatr Hematol Oncol 2000 0.75
52 Therapy for acute myeloid leukemia: intensive timing of induction chemotherapy. Curr Oncol Rep 2000 0.75
53 Differentiation responses of embryonic endothelium to leukemia inhibitory factor. Exp Cell Res 1998 0.75